Gilead Sciences, Inc.
GILD
$79.02
$0.971.24%
| Weiss Ratings | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B+ | |||
| Rating Factors | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.41 | |||
| Price History | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.16% | |||
| 30-Day Total Return | 3.13% | |||
| 60-Day Total Return | 4.43% | |||
| 90-Day Total Return | 4.67% | |||
| Year to Date Total Return | -7.68% | |||
| 1-Year Total Return | -10.56% | |||
| 2-Year Total Return | 13.49% | |||
| 3-Year Total Return | 33.96% | |||
| 5-Year Total Return | 20.89% | |||
| 52-Week High % Change | -11.95% | |||
| 52-Week Low % Change | 8.45% | |||
| Price | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $89.74 | |||
| 52-Week Low Price | $72.87 | |||
| 52-Week Low Price (Date) | Oct 03, 2023 | |||
| 52-Week High Price (Date) | Dec 13, 2022 | |||
| Valuation | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $98.46B | |||
| Enterprise Value | 114.24B | |||
| Price/Earnings (TTM) | 16.96 | |||
| Earnings Per Share (TTM) | 4.66 | |||
| Earnings Per Share Growth | 76.17% | |||
| Price/Earnings To Growth | 0.22 | |||
| Price/Sales (TTM) | 3.63 | |||
| Price/Book (Q) | 4.42 | |||
| Enterprise Value/Revenue (TTM) | 4.17 | |||
| Price | $79.02 | |||
| Enterprise Value/EBITDA (TTM) | 9.73 | |||
| Enterprise Value/EBIT | 12.40 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.257B | |||
| Dividend Yield | 3.77% | |||
| Div. Per Share (Most Recent) | $0.75 | |||
| Dividend Per Share (TTM) | $2.98 | |||
| Payout Ratio (TTM) | 64.36% | |||
| Dividend Per Share (Most Recent) | $0.75 | |||
| Company Info | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 574 3000 | |||
| Address | 333 Lakeside Drive Foster City, CA 94404 | |||
| Website | www.gilead.com | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 33.63% | |||
| Profit Margin | 21.44% | |||
| Management Effectiveness | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 9.22% | |||
| Return on Equity | 26.92% | |||
| Income Statement | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $27.39B | |||
| Total Revenue (TTM) | $27.39B | |||
| Revenue Per Share | $21.79 | |||
| Gross Profit (TTM) | $21.59B | |||
| EBITDA (TTM) | $11.75B | |||
| EBIT (TTM) | $9.21B | |||
| Net Income (TTM) | $5.88B | |||
| Net Income Avl. to Common (TTM) | $5.88B | |||
| Total Revenue Growth (Q YOY) | 0.11% | |||
| Earnings Growth (Q YOY) | 21.61% | |||
| EPS Diluted (TTM) | $4.66 | |||
| EPS Diluted Growth (Q YOY) | 21.83% | |||
| Balance Sheet | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $7.97B | |||
| Cash Per Share (Q) | $6.34 | |||
| Total Current Assets (Q) | $15.98B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $22.24B | |||
| Current Ratio (Q) | 1.338 | |||
| Book Value Per Share (Q) | $17.89 | |||
| Total Assets (Q) | $62.37B | |||
| Total Current Liabilities (Q) | $11.95B | |||
| Total Debt (Q) | $24.98B | |||
| Total Liabilities (Q) | $40.13B | |||
| Total Common Equity (Q) | $22.31B | |||
| Cash Flow | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$1.91B | |||
| Cash from Financing (TTM) | -$5.58B | |||
| Net Change in Cash (TTM) | $1.01B | |||
| Levered Free Cash Flow (TTM) | $8.82B | |||
| Cash from Operations (TTM) | $8.40B | |||
